Development and characterization of lyophilized cefpodoxime proxetil-Pluronic^® F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity

References

• Abd Alaziz DM, Sammour OA, Elshamy AEAA, Neseem DI. 2014. Formulation and evaluation of binary and ternary solid dispersions of domperidone by solvent evaporation method. Afr J Pharm Pharmacol. 8(3):66–80.
   Google Scholar
• Ali W, Williams AC, Rawlinson CF. 2010. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. Int J Pharm. 391(1–2):162–168.
   PubMed Web of Science ®Google Scholar
• Alves TF, Chaud MV, Grotto D, Jozala AF, Pandit R, Rai M, Dos Santos CA. 2018. Association of silver nanoparticles and curcumin solid dispersion: antimicrobial and antioxidant properties. AAPS PharmSciTech. 19(1):225–231.
   PubMed Web of Science ®Google Scholar
• Arora SC, Sharma PK, Irchhaiya R, Khatkar A, Singh N, Gagoria J. 2010. Development, characterization and solubility study of solid dispersion of cefpodoxime proxetil by solvent evaporation method. Int J ChemTech Res. 2(2):1156–1162.
   Google Scholar
• Bangun H, Arianto A, Bangun YS, Nainggolan M. 2019. Antibacterial activity of mucoadhesive gastroretentive drug delivery system of alginate beads containing turmeric Extract - PVP Solid Dispersion. Open Access Maced J Med Sci. 7(22):3868–3873.
   PubMedGoogle Scholar
• Betageri GV, Makarla KR. 1995. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm. 126(1-2):155–160.
   Web of Science ®Google Scholar
• Bhargava S, Agrawal GP. 2008. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with β-cyclodextrin. Curr Drug Deliv. 5(1):1–6.
   PubMedGoogle Scholar
• Bikiaris DN. 2011. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv. 8(11):1501–1519.
   PubMed Web of Science ®Google Scholar
• Borin MT. 1991. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs. 42:13–21.
   PubMedGoogle Scholar
• Chiou WL, Riegelman S. 1971. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 60(9):1281–1302.
   PubMed Web of Science ®Google Scholar
• [CLSI] Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th ed. Wayne (PA): CLSI standard M07.
   Google Scholar
• Craig DQ. 2002. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 231(2):131–144.
   PubMed Web of Science ®Google Scholar
• Crauste-Manciet S, Brossard D, Decroix MO, Farinotti R, Chaumeil JC. 1998. Cefpodoxime proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions. Int J Pharm. 165(1):97–106.
   Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. 2007. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 329(1–2):166–172.
   PubMedGoogle Scholar
• Dhoka MV, Nimbalkar UA, Pande A. 2011. Preparation of cefpodoxime proxetil-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J PharmTech Res. 3(1):411–419.
   Google Scholar
• Dhoka MV, Rao SH, Joshi PP, Gawande VT. 2009. Preparation and evaluation of solid dispersions of cefpodoxime proxetil. J Pharm Res. 2(9):1481–1484.
   Google Scholar
• Diaz DA, Colgan ST, Langer CS, Bandi NT, Likar MD, Alstine LV. 2016. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? AAPS J. 18(1):15–22.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fathy M. 2006. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm. 32(2):141–150.
   PubMed Web of Science ®Google Scholar
• Faisal Ali S, Joshi M, Akhtar N, Sharma V, Pathak K. 2016. Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan. Pharm Biomed Res. 2(1):23–35.
   Google Scholar
• Fathy M, Sheha M. 2000. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropylbetacyclodextrin complex prepared by a freeze-drying method. Pharmazie. 55:513–517.
   PubMed Web of Science ®Google Scholar
• FDA. 2020. Guidance for industry dissolution testing of immediate release solid oral dosage forms. [accessed 2020 Feb 29]:[17 p.]. https://www.fda.gov/media/70936/download.
   Google Scholar
• Fitriani L, Ismed F, Bakhtiar A. 2019. Hydrogel formulation of usnic acid and antibacterial activity test against Propionibacterium acne. Sci Pharm. 87(1):1–8.
   Web of Science ®Google Scholar
• Fu X, Huck D, Makein L, Armstrong B, Willen U, Freeman T. 2012. Effect of particle shape and size on flow properties of lactose powders. Particuology. 10(2):203–208.
   Web of Science ®Google Scholar
• Fusco S, Borzacchiello A, Netti PA. 2006. Perspectives on: PEO-PPOPEO triblock copolymers and their biomedical applications. J Bioact Compat Pol. 21(2):149–164.
   Web of Science ®Google Scholar
• Gao Y, Qian S, Zhang J. 2010. Physicochemical and pharmakokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension. Chem Pharm Bull. 58(7):912–917.
   PubMed Web of Science ®Google Scholar
• Ghaderkhani J, Yousefimashouf R, Arabestani M, Roshanaei G, Asl SS, Abbasalipourkabir R. 2019. Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus. Artif Cell Nanomed B. 47(1):1181–1193.
   PubMed Web of Science ®Google Scholar
• Gundogdu E, Koksal C, Karasulu E. 2012. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer. Drug Dev Ind Pharm. 38(6):689–696.
   PubMed Web of Science ®Google Scholar
• Gupta S, Munjal T, Kaur A, Bagga KS. 2014. Fabrication and characterization of cefpodoxime proxetil solid dispersion for solubility enhancement. Int J Pharm Sci Drug Res. 6(4):271–277.
   Google Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. 2005. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol Pharm. 2(5):384–391.
   PubMedGoogle Scholar
• Gyulai G, Magyar A, Rohonczy J, Orosz J, Yamasaki M, Bosze S, Kiss E. 2016. Preparation and characterization of cationic Pluronic for surface modification and functionalization of polymeric drug delivery nanoparticles. Express Polym Lett. 10(3):216–224.
   Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Leo E, Fontana F, Bernabei MT. 2000. PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. Drug Dev Ind Pharm. 26(6):595–603.
   PubMed Web of Science ®Google Scholar
• Ismail MY, Ghareeb MM. 2018. Enhancement of the solubility and dissolution rate of rebamipide by using solid dispersion technique (Part I). Iraqi J of Pharm Sci. 27(2):55–65.
   Google Scholar
• Jatinder K, Aggarwal G, Singh G, Rana AC. 2012. Improvement of drug solubility using solid dispersion. Int J Pharm Pharm Sci. 4:47–53.
   Google Scholar
• Junior SAF, Barbosa IS, Santos VLD, Silva RL, Junior EC. 2014. Test of dissolution and comparison of in vitro dissolution profiles of coated ranitidine tablets marketed in Bahia, Brazil. Braz J Pharm Sci. 50(1):83–89.
   Web of Science ®Google Scholar
• Kakumanu VK, Arora V, Bansal AK. 2006. Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. Int J Pharm. 317(2):155–160.
   PubMedGoogle Scholar
• Karolewicz B, Gajda M, Górniak A, Owczarek A, Mucha I. 2017. Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms. J Therm Anal Calorim. 130(1):383–390.
   Web of Science ®Google Scholar
• Karolewicz B, Gajda M, Owczarek A, Pluta J, Górniak A. 2014. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127. Pharmazie. 69(8):589–594.
   PubMed Web of Science ®Google Scholar
• Kassem AA, Zaki SA, Mursi NM, Tayel SA. 1979. Antimicrobial activity of chloramphenicol in solid dispersion systems. Pharmazie. 34(1):43–44.
   PubMed Web of Science ®Google Scholar
• Kawakami K. 2012. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev. 64(6):480–495.
   PubMed Web of Science ®Google Scholar
• Khan F, Katara R, Ramteke S. 2010. Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles. AAPS PharmSciTech. 11(3):1368–1375.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee JH, Yoon H, Kim SJ, Jeon DY, Jang JE, Lee D, Khang G. 2013. Preparation, characterization and in vitro dissolution of aceclofenac-loaded PVP solid dispersions prepared by spray drying or rotary evaporation method. J Pharm Investig. 43(2):107–113.
   Google Scholar
• Kim NA, Oh HK, Lee JC, Choi YH, Jeong SH. 2020. Comparison of solubility enhancement by solid dispersion and micronized butein and its correlation with in vivo study. J Pharm Investig. [accessed 2020 Apr 24]:[8 p.] https://doi.org/https://doi.org/10.1007/s40005-020-00486-9.
   Google Scholar
• Kolašinac N, Kachrimanis K, Homšek I, Grujić B, Ðurić Z, Ibrić S. 2012. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 436(1–2):161–170.
   PubMed Web of Science ®Google Scholar
• Kukati L, Chittimalli K, Shaik NB. 2014. Formulation and evaluation of floating tablets of cefpodoxime proxetil. J Sci Res. 6(3):563–579.
   Google Scholar
• Kumar P, Mohan C, Shankar MKSU, Gulati M. 2011. Physiochemical characterization and release rate studies of solid dispersions of ketoconazole with Pluronic F127 and PVP K-30. Iran J Pharm Res. 10(4):685–694.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50(1):47–60.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Li T, Taylor LS. 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res. 26(1):139–151.
   PubMed Web of Science ®Google Scholar
• Medarevic DP, Kachrimanis K, Mitric M, Djuris J, Djuric Z, Ibric S. 2016. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol. 21(3):268–276.
   PubMed Web of Science ®Google Scholar
• Muratkar D, Untwali L, Naik J. 2012. Preparation and characterization of biodegradable cefpodoxime proxetil nanocapsules. Asian J Pharm Sci. 7(2):143–148.
   Google Scholar
• Nepal PR, Han HK, Choi HK. 2010. Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation. Int J Pharm. 383(1–2):147–153.
   PubMedGoogle Scholar
• Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, Choi HG. 2007. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 343(1–2):228–237.
   PubMed Web of Science ®Google Scholar
• Nimbalkar UA, Dhoka MV, Sonawane PA. 2011. Solid lipid nanoparticles for enhancement of oral bioavailability of cefpodoxime proxetil. IJPRS. 2(11):2974–2982.
   Google Scholar
• Pandit JK, Khakurel BK. 1984. In vitro and in vivo evaluation of some fast release dosage forms of hydrochlorothiazide. Drug Dev Ind Pharm. 10(10):1709–1724.
   Web of Science ®Google Scholar
• Papageorgiou GZ, Bikiaris D, Kanaze FI, Karavas E, Stergiou A, Georgarakis E. 2008. Tailoring the release rates of fluconazole using solid dispersions in polymer blends. Drug Dev Ind Pharm. 34(3):336–346.
   PubMed Web of Science ®Google Scholar
• Park J, Cho W, Cha KH, Ahn J, Han K, Hwang SJ. 2013. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process. Int J Pharm. 441(1–2):50–55.
   PubMedGoogle Scholar
• Ramadhani N, Shabir M, McConville C. 2014. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram. Int J Pharm. 475(1–2):514–522.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Aller M, Guillarme D, Veuthey JL, Gurny R. 2015. Strategies for formulating and delivering poorly water-soluble drugs. J Drug Deliv Sci Technol. 30:342–351.
   Web of Science ®Google Scholar
• Sankari T, Al-Hariri S. 2018. Preparation and characterization of cefuroxime axetil solid dispersions using poloxamer 188. Braz J Pharm Sci. 54(4):e17644.
   Web of Science ®Google Scholar
• Sareen S, Mathew G, Joseph L. 2012. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2(1):12–17.
   PubMedGoogle Scholar
• Savjani KT, Gajjar AK, Savjani JK. 2012. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012:195727.
   PubMedGoogle Scholar
• Shabir GA. 2003. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J Chromatogr A. 987(1–2):57–66.
   PubMed Web of Science ®Google Scholar
• Sharma A, Jain CP. 2010. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 5(1):49–56.
   PubMedGoogle Scholar
• Singh A, Mooter GV. 2016. Spray drying formulation of amorphous solid dispersions . Adv Drug Deliv Rev. 100:27–50.
   PubMed Web of Science ®Google Scholar
• Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. 2010. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech. 11(2):518–527.
   PubMed Web of Science ®Google Scholar
• Song CK, Yoon IS, Kim DD. 2016. Poloxamer-based solid dispersions for oral delivery of docetaxel: differential effects of F68 and P85 on oral docetaxel bioavailability. Int J Pharm. 507(1–2):102–108.
   PubMed Web of Science ®Google Scholar
• Thybo P, Pedersen BL, Hovgaard L, Holm R, Müllertz A. 2008. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol. 13(5):375–386.
   PubMed Web of Science ®Google Scholar
• Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. 2019. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 11(3):132.
   PubMed Web of Science ®Google Scholar
• Vo CLN, Park C, Lee BJ. 2013. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 85(3 Pt B):799–813.
   PubMed Web of Science ®Google Scholar
• Wiswaja M, Bhikshapathi DVRN. 2018. Improvement of solubility and dissolution of rilpivirine solid dispersions by solvent evaporation technique and novel carriers. Int J Pharm Sci Nanotech. 11(4):4177–4184.
   Google Scholar
• Xu H, Kuo SW, Huang CF, Chang FC. 2004. Characterization of poly (vinyl pyrrolidone‐co‐isobutylstyryl polyhedral oligomeric silsesquioxane) nanocomposites. J Appl Polym Sci. 91(4):2208–2215.
   Web of Science ®Google Scholar
• Yurtdaş G, Demirel M, Genç L. 2011. Inclusion complexes of fluconazole with β-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation. J Incl Phenom Macrocycl Chem. 70(3–4):429–435.
   Web of Science ®Google Scholar
• Yurtdaş-Kırımlıoğlu G. 2019. A systematic evaluation of formulation parameters on the characteristics of biodegradable PLGA-based nanoparticles for ophthalmic application. Lat Am J Pharm. 38(11):2131–2142.
   Web of Science ®Google Scholar
• Yurtdaş-Kırımlıoğlu G. 2020. Host-guest inclusion complex of desloratadine with 2-(hydroxy)propyl-β-cyclodextrin (HP-β-CD): preparation, binding behaviors and dissolution properties. J Res Pharm. 24(5):693–707.
   Google Scholar
• Yurtdaş-Kırımlıoğlu G. 2021. A promising approach to design thermosensitive in situ gel based on solid dispersions of desloratadine with Kolliphor® 188 and Pluronic® F127. J Therm Anal Calorim. [accessed 2021 Jan 5]:[21 p.]. https://doi.org/https://doi.org/10.1007/s10973-020-10460-0.
   Google Scholar
• Yurtdaş-Kırımlıoğlu G, Görgülü Ş. 2021. Surface modification of PLGA nanoparticles with Chitosan or Eudragit® RS 100: characterization, prolonged release, cytotoxicity, and enhanced antimicrobial activity. J Drug Dev Tech. 61:102145.
   Web of Science ®Google Scholar
• Zhang X, Xing H, Zhao Y, Ma Z. 2018. Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs. Pharmaceutics. 10(3):74.
   PubMed Web of Science ®Google Scholar